FDA’s Patent-Based Approach Of Awarding Generic Exclusivity Upheld In Federal Court
This article was originally published in The Pink Sheet Daily
Executive Summary
Apotex is blocked from marketing a 40 mg generic of AstraZeneca’s Prilosec until April 2008.